Clinical Benefit of Tamsulosin and the Hexanic Extract of Serenoa Repens, in Combination or as Monotherapy, in Patients with Moderate/Severe LUTS-BPH: A Subset Analysis of the QUALIPROST Study

To investigate whether tamsulosin (TAM) and the hexanic extract of Serenoa repens (HESr) are more effective in combination than as monotherapy in men with moderate-to-severe lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH). Subset analysis of data from a 6-month,...

Descripción completa

Detalles Bibliográficos
Autores principales: Alcaraz, Antonio, Rodríguez-Antolín, Alfredo, Carballido-Rodríguez, Joaquín, Castro-Díaz, David, Esteban-Fuertes, Manuel, Cózar-Olmo, José M., Ficarra, Vincenzo, Medina-López, Rafael, Fernández-Gómez, Jesús M., Angulo, Javier C., Medina-Polo, José, Brenes-Bermúdez, Francisco J., Molero-García, José M., Fernández-Pro-Ledesma, Antonio, Manasanch, José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564885/
https://www.ncbi.nlm.nih.gov/pubmed/32917008
http://dx.doi.org/10.3390/jcm9092909

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564885/
https://www.ncbi.nlm.nih.gov/pubmed/32917008
http://dx.doi.org/10.3390/jcm9092909

Ejemplares similares